Atezolizumab for the First-Line Treatment of Non-small Cell Lung Cancer (NSCLC): Current Status and Future Prospects

by Rachel Ryu, Kristina E. Ward
Published 2018-07-01

Critical Analysis of Apixaban Dose Adjustment Criteria

by Anh Vu PharmD, Tao T. Qu PharmD, Rachel Ryu PharmD, BCPS, Shuktika Nandkeolyar MD, Alan Jacobson MD, Lisa T. Hong PharmD, BCPS
Published 2021-06-01